Eli Lilly to pledge $30M to MDR-TB partnership
Pharmaceutical firm Eli Lilly and Co. is expected to announce on Tuesday it "is pledging $30 million to help fight multidrug-resistant tuberculosis [MDR-TB] in developing countries, a disease that kills more than 150,000 people a year," according to the Indianapolis Star.
The funds, part of the company's eight-year-old, $165 million Lilly MDR-TB Partnership, will help to "provide training for nurses, doctors and community volunteers; conduct studies on how to combat the disease; and provide access to medicines," the newspaper notes. The campaign will focus on China, India, Russia and South Africa, "the four countries with the highest burden of MDR-TB, Lilly said," the Indianapolis Star writes (10/25).
Kaiser Daily Global Health Policy Report
http://globalhealth.kff.org/Daily-Reports/2011/October/25/GH-102511-Eli-Lilly-MDRTB.aspx
